Exome sequencing in familial corticobasal degeneration

Parkinsonism and Related Disorders

Volumn 19, Issue 11, 2013, Pages 1049-1052

  Fekete, Robert ^a   Bainbridge, Matthew ^a   Baizabal Carvallo, Jose Fidel ^a   Rivera, Andreana ^b   Miller, Bradley ^c   Du, Peicheng ^d   Kholodovych, Vladyslav ^d   Powell, Suzanne ^b   Ondo, William ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Apraxia; Corticobasal degeneration; Corticobasal syndrome; Genetics; Progressive supranuclear palsy

Indexed keywords

LEVODOPA; MICRORNA; MICRORNA 4277; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; APRAXIA; ARTICLE; AUTOPSY; BASAL GANGLION; CASE REPORT; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DRUG MEGADOSE; DYSTONIA; EXOME; FEMALE; GAIT DISORDER; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MRS2 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; SENSORY DYSFUNCTION; THALAMUS; TREMOR; ZHX2 GENE;

APRAXIA; CORTICOBASAL DEGENERATION; CORTICOBASAL SYNDROME; GENETICS; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; BASAL GANGLIA DISEASES; EXOME; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MALE; PEDIGREE; SEQUENCE ANALYSIS, DNA;

EID: 84886583911     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.06.016     Document Type: Article

References (12)

1. Mathew R., Bak T.H., Hodges J.R. Diagnostic criteria for corticobasal syndrome: a comparative study. JNeurol Neurosurg Psychiatr 2012, 83:405-410.
2. Double K.L., Jellinger K., Zecca L., Youdim M.B.H. Iron, neuromelanin, and alpha-synuclein in neuropathogenesis of Parkinson's disease. Metal ions and neurodegenerative disorders 2003, 343-364. World Scientific Publishing Co., Singapore. P.F. Zatta (Ed.).
3. Mizuno Y., Ozeki M., Iwata H., Takeuchi T., Ishihara R., Hashimoto N., et al. Acase of clinically and neuropathologically atypical corticobasal degeneration with widespread iron deposition. Acta Neuropathol 2002, 103:288-294.
4. Molinuevo J.L., Munoz E., Valldeoriola F., Tolosa E. The eye of the tiger sign in cortical-basal ganglionic degeneration. Mov Disord 1999, 14:169-171.
5. Houlden H., Baker M., Morris H.R., MacDonald M., Pickering-Brown S., Adamson J., et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001, 56:1702-1706.
6. Rossi G., Marelli C., Farina L., Laurà M., Basile A.M., Ciano C., et al. The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov Disord 2008, 23:892-895.
7. Coppola C., Rossi G., Barbarulo A.M., Di Fede G., Foglia C., Piccoli E., et al. Aprogranulin mutation associated with cortico-basal syndrome in an Italian family expressing different phenotypes of fronto-temporal lobar degeneration. Neurol Sci 2012, 33:93-97.
8. Chen-Plotkin A.S., Yuan W., Anderson C., Wood E.M., Hurtig H.I., Clark C.M., et al. Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology 2008, 70:521-527.
9. Rajput A., Dickson D.W., Robinson C.A., Ross O.A., Dächsel J.C., Lincoln S.J., et al. Parkinsonism, LRRK2 G2019S, and tau neuropathology. Neurology 2006, 67:1506-1508.
10. Bainbridge M.N., Wang M., Wu Y., Newsham I., Muzny D.M., Jefferies J.L., et al. Targeted enrichment beyond the consensus coding DNA sequence exomereveals exons with higher variant densities. Genome Biol 2011, 12:R68.
11. Bainbridge M.N., Wang M., Burgess D.L., Kovar C., Rodesch M.J., D'Ascenzo M., et al. Whole exome capture in solution with 3 Gbp of data. Genome Biol 2010, 11:R62.
12. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.